• SENSEX
    NIFTY 50
Market

Strides Pharma Science surges 11% on development of Favipiravir; claims drug effectiveness against COVID-19

Updated : April 29, 2020 10:17 AM IST

The stock rose as much as 8.4 percent to Rs 408 per share on BSE.
Favipiravir tablets have demonstrated positive outcomes in COVID-19 treatment globally.
Strides Pharma is the first Indian Company to have commenced the export of Favipiravir tablets.
Strides Pharma Science surges 11% on development of Favipiravir; claims drug effectiveness against COVID-19

You May Also Like

Live TV
Advertisement